Literature DB >> 22897884

Hepatocellular carcinoma in an adult with repaired tetralogy of fallot.

Nancy McCabe1, Alton Brad Farris, Huiming Hon, Ryan Ford, Wendy M Book.   

Abstract

Liver fibrosis is a growing concern among adults with congenital heart disease, particularly for those who have undergone a Fontan operation. Liver fibrosis leads to cirrhosis, a precursor of hepatocellular carcinoma. A few cases of hepatocellular carcinoma in patients with prior palliative surgery for congenital heart disease have been identified in the literature. The current case reports the first known case of hepatocellular carcinoma in a 45-year-old male with repaired tetralogy of Fallot.
© 2012 Wiley Periodicals, Inc.

Entities:  

Keywords:  Cirrhosis; Congenital Heart Disease; Hepatocellular Carcinoma; Tetralogy of Fallot

Mesh:

Year:  2012        PMID: 22897884     DOI: 10.1111/j.1747-0803.2012.00700.x

Source DB:  PubMed          Journal:  Congenit Heart Dis        ISSN: 1747-079X            Impact factor:   2.007


  4 in total

1.  Surveillance for hepatocellular carcinoma secondary to cardiogenic cirrhosis in patients with congenital heart disease.

Authors:  Alexander Augustyn; Lan Peng; Amit G Singal; Adam C Yopp
Journal:  Clin Res Cardiol       Date:  2015-01-21       Impact factor: 5.460

Review 2.  Congenital heart disease-associated liver disease: a narrative review.

Authors:  Florian P Reiter; Nino J Hadjamu; Nicole Nagdyman; Reinhart Zachoval; Julia Mayerle; Enrico N De Toni; Harald Kaemmerer; Gerald Denk
Journal:  Cardiovasc Diagn Ther       Date:  2021-04

Review 3.  Hepatocellular Carcinoma in a Patient with Tetralogy of Fallot: A Case Report and Literature Review.

Authors:  Ji Hyun Sung; Ryotaro Sakamori; Ryoko Yamada; Teppei Yoshioka; Sadatsugu Sakane; Yuki Tahata; Minoru Shigekawa; Takahiro Kodama; Hayato Hikita; Tomohide Tatsumi; Tetsuo Takehara
Journal:  Intern Med       Date:  2021-10-19       Impact factor: 1.282

4.  Low Cardiac Output Leads Hepatic Fibrosis in Right Heart Failure Model Rats.

Authors:  Yoshitaka Fujimoto; Takashi Urashima; Daisuke Shimura; Reiji Ito; Sadataka Kawachi; Ichige Kajimura; Toru Akaike; Yoichiro Kusakari; Masako Fujiwara; Kiyoshi Ogawa; Nobuhito Goda; Hiroyuki Ida; Susumu Minamisawa
Journal:  PLoS One       Date:  2016-02-10       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.